Skip to main content

Advertisement

Log in

Use of the University of California Los Angeles Integrated Staging System (UISS) to predict survival in localized renal cell carcinoma in an Asian population

  • Original paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate the applicability of the University of California Los Angeles Integrated Staging System (UISS) in predicting the prognosis of Chinese patients with localized renal cell carcinoma after radical nephrectomy, with reference to that reported by Patard et al in an international multicenter study (J Clin Oncol 2004, 22:3316–3322).

Methodology

One hundred and twenty-eight Chinese patients with localized renal cell carcinoma were stratified into low risk (LR), intermediate risk (IR) and high risk (HR) groups according to the UISS, based on the TMN staging and Fuhrman grading of the tumor and the Eastern Cooperative Oncology Group performance status of the patients. The survival curves of each risk group were then calculated.

Results

The number of patients in the LR, IR and HR was 24 (18.8%), 94 (73.4%) and 10 (7.8%) respectively. The estimated 2-year survival rates were 100%, 89.9% and 100% for the LR, IR and HR groups respectively. Whereas the estimated 5-year survival rates were 93.3%, 72.4% and 80% for the LR, IR and HR groups respectively. The LR and IR patients had comparable 2-year and 5-year estimated survival rates with those reported by Patard et al. However, the estimated survival rate for HR patients was better than that reported.

Conclusions

UISS provided a valuable tool in predicting the survival of Chinese patients with localized renal cell carcinoma of LR and IR groups, as reported in other international centers. Further large scale study may be needed to confirm the applicability in HR population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Chow WH, Devesa SS, Warren JL, et al (1999) Rising incidence of renal cell cancer in the United States. JAMA 281:1628–1631

    Article  PubMed  CAS  Google Scholar 

  2. Pantuck AJ, Zisman A, Belldegrun AS (2001) The Changing natural history of renal cell carcinoma. J Urol 166:1611–1623

    Article  PubMed  CAS  Google Scholar 

  3. Kontak JA, Campbell SC (2003) Prognostic factors in renal cell carcinoma. Urol Clin North Am 30:467–480

    Article  PubMed  Google Scholar 

  4. Zisman A, Pantuck AJ, Dorey F, et al (2001) Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19:1649–1657

    PubMed  CAS  Google Scholar 

  5. Zisman A, Pantuck AJ, Wieder J, et al (2002) Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 20:4559–4566

    Article  PubMed  Google Scholar 

  6. Kattan MW, Reuter V, Motzer R, et al (2001) A postoperative prognostic nomogram for renal cell carcinoma. J Urol 166:63–67

    Article  PubMed  CAS  Google Scholar 

  7. Frank I, Blute ML, Cheville JC, et al (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168:2395–2400

    Article  PubMed  Google Scholar 

  8. Patard JJ, Kim HL, Lam JS, et al (2004) Use of the University of California Los Angeles Integrated Staging System to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 22:3316–3322

    Article  PubMed  Google Scholar 

  9. Sorbellini M, Kattan MW, Snyder ME, et al (2005) A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 173:48–51

    Article  PubMed  Google Scholar 

  10. Ficarra V, Martignoni G, Lohse C, et al (2006) External validation of the Mayo Clinic Stage, Size, Grade and Necrosis (SSIGN) score to predict cancer specific survival using a European series of conventional renal cell carcinoma. J Urol 175:1235–1239

    Article  PubMed  Google Scholar 

  11. Millward MJ, Boyer MJ, Lehnert M, et al (2003) Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients. Ann Oncol 14:449–454

    Article  PubMed  CAS  Google Scholar 

  12. Hashibe M, Gao T, Li G, et al (2003) Comparison of bladder cancer survival among Japanese, Chinese, Hawaiian and Caucasian populations in the United States. Asian Pac J Cancer Prev 4:267–273

    PubMed  Google Scholar 

  13. Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment and survival by race and ethnicity. Arch Intern Med 163:49–56

    Article  PubMed  Google Scholar 

  14. Furhaman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663

    Article  Google Scholar 

  15. Guinan P, Sobin LH, Alagaba F, et al (1997) TNM staging of renal cell carcinoma: workgroup no 3—Union International Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80:992–993

    Article  PubMed  CAS  Google Scholar 

  16. Oken MM, Creech RH, Tormey DC, et al. (1982) Toxicity and Response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655

    Article  PubMed  CAS  Google Scholar 

  17. Prehn AW, Topol B, Stewart S, et al (2002) Differences in treatment patterns for localized breast carcinoma among Asian/Pacific islander women. Cancer 95:2268–2275

    Article  PubMed  Google Scholar 

  18. Tseng JF, Kronowitz SJ, Sun CC et al: The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer, 2004; 101: 1514–1523. http://www.ncbi.nlm.nih.gov/entrez/utils/lofref.fcgi?PrId=3058&uid=15378473&db=pubmed&url=http://dx.doi.org/10.1002/cncr.20529

    Google Scholar 

  19. Wisnivesky JP, McGinn T, Henschke C, et al (2005) Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med 171:1158–63

    Article  PubMed  Google Scholar 

  20. Yang KS: Do traditional and modern values coexist in a modern Chinese society? In: Proceedings of the conference on Chinese perspectives on values. Taipei: Centre for sinological studies; 1992: 117–158

  21. Ip M, Gilligan T, Koenig B, Raffin T (1998) Ethical decision-making in critical care in Hong Kong. Crit Care Med 26:447–451

    Article  PubMed  CAS  Google Scholar 

  22. Murphy AM, Gilbert SM, Katz AE, et al (2005) Re-evaluation of the Tumour-Node-Metastasis staging of locally advanced renal cortical tumours: absolute size (T2) is more significant than renal capsular invasion (T3a). BJU int 95:27–30

    Article  PubMed  Google Scholar 

  23. Siemer S, Lehmann J, Loch A, et al (2005) Current TNM classification of renal cell carcinoma evaluated: revising stage T3a. J Urol 173:33–37

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chi-Fai Ng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ng, CF., Wan, SH., Wong, A. et al. Use of the University of California Los Angeles Integrated Staging System (UISS) to predict survival in localized renal cell carcinoma in an Asian population. Int Urol Nephrol 39, 699–703 (2007). https://doi.org/10.1007/s11255-006-9134-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-006-9134-1

Keywords

Navigation